Grab Holdings Ltd. vs Zoetis Inc — how do they compare? Grab Holdings Ltd. trades at $3.2 (market cap $12.72B), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 2.4× Grab Holdings Ltd.'s market cap, and Zoetis Inc pays a 2.9% dividend while Grab Holdings Ltd. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Grab Holdings Ltd. for 94 Days and Zoetis Inc for 70 Days on average.
| GRAB | ZTS | |
|---|---|---|
Market Cap | $12.72B | $30.20B |
Volume | 65,352,859 | 6,175,327 |
Sector | Technology | Health |
52-Week High | $6.17 | $147.53 |
52-Week Low | $2.80 | $69.09 |
Typical Hold Time | 94 Days | 70 Days |
Enterprise Value | $8.46B | $37.76B |
Dividend Yield | — | 2.9% |
Signals from Pluang's Aura AI — not financial advice
GRAB trades at $3.19, up 3.57% today, with a bearish technical signal but strong fundamental momentum. The company has delivered three consecutive quarterly EPS beats, with Q2 2026 revenue up 22% year-over-year to $997 million. Recent news highlights a $1.49 billion acquisition of a majority stake in Atome Financial and a $30 million CEO share purchase, signaling confidence in growth. Cash flow trends show volatility, with 2025 net cash flow positive at $469 million but a projected decline to -$1.0 billion in 2026.
The outlook for GRAB is supported by robust revenue growth, expanding profitability, and aggressive financial services expansion, but risks include high capital expenditure, competitive pressures in Southeast Asia, and potential regulatory scrutiny. Analyst consensus is strongly bullish with 91.67% buy ratings, though technical indicators suggest near-term caution. The stock's valuation at a P/E of 28.27 reflects growth expectations but requires sustained execution to justify.
Zoetis (ZTS) trades at $74.77, up 4.5% with strong profitability metrics including 71.67% gross margins and 27.69% net income margin. The stock shows mixed technical signals with bullish oscillators but bearish moving averages, trading near resistance at $75. Recent earnings show beats in Q4 2025 and Q2 2026 but a miss in Q1 2026, with Q3 2026 results pending. The company maintains robust cash flow generation despite competitive pressures in the U.S. companion animal market.
Zoetis presents a compelling value opportunity with a P/E of 11.92 below industry averages, though near-term headwinds from pet care weakness and competition persist. Analyst consensus targets $87.33 with no sell ratings, suggesting 17% upside potential. Key risks include ongoing margin pressure and market share challenges, but strong international growth and dividend sustainability support long-term bullish thesis.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.
Read more on GRAB →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →